- CONSORT Statement
- CONSORT Statement Extensions
- Evidence underpinning CONSORT
- Accrual and sample size
- Attitudes to trials
- Adverse events (Harms)
- Baseline data
- Blinding
- Compliance
- Early stopping
- Eligibility
- Follow-up
- Funding
- Generalizability
- Harms
- Intention to treat
- Interpretation
- Interventions
- Outcome reporting
- Random allocation
- Recruitment
- Statistical analysis
- Statistical methods
- Trial design issues
- Trial registration
- Uptake of CONSORT by journals
- Impact of and adherence to CONSORT
- Endorsement of CONSORT
Intention to treat
Begg CB. Ruminations on the intent-to-treat
principle. Control Clin Trials 2000; 21(3):241-243.
PMID: 10822121
Ewart R, Lausen H, Millian N. Undisclosed changes in outcomes in randomized
controlled trials: an observational study. Ann Fam Med 2009; 7(6):542-546.
PMID: 19901314 [New]
Gravel J, Opatrny L, Shapiro S. The intention-to-treat approach in randomized
controlled trials: are authors saying what they do and doing what they say? Clin
Trials 2007; 4(4):350-356.
PMID: 17848496 [New]
Herman A, Botser IB, Tenenbaum S, Chechick A. Intention-to-treat analysis and
accounting for missing data in orthopaedic randomized clinical trials. J Bone
Joint Surg Am 2009; 91(9):2137-2143.
PMID: 19723990 [New]
Hollis S, Campbell F. What is meant by intention to treat
analysis? Survey of published randomised controlled trials. BMJ 1999;
319(7211):670-674.
PMID: 10480822
Kruse RL, Alper BS, Reust C, Stevermer JJ, Shannon S, Williams RH.
Intention-to-treat analysis: who is in? Who is out? J Fam Pract 2002;
51(11):969-971.
PMID: 12485553 [New]
Lachin JM. Statistical considerations in the
intent-to-treat principle. Control Clin Trials 2000; 21(3):167-189.
PMID: 10822117
Lee YJ, Ellenberg JH, Hirtz DG, Nelson KB. Analysis of
clinical trials by treatment actually received: is it really an option? Stat
Med 1991; 10(10):1595-1605.
PMID: 1947515
Lewis JA, Machin D. Intention to treat-who should use ITT?
Br J Cancer 1993; 68(4):647-650.
PMID: 8398686
May GS, DeMets DL, Friedman LM, Furberg C, Passamani E. The
randomized clinical trial: bias in analysis. Circulation 1981; 64(4):669-673.
PMID: 7023743
Nagelkerke N, Fidler V, Bernsen R, Borgdorff M. Estimating
treatment effects in randomized clinical trials in the presence of
non-compliance. Stat Med 2000; 19(14):1849-1864.
PMID: 10867675
Ruiz-Canela M, Martinez-Gonzalez MA, de Irala-Estevez J.
Intention to treat analysis is related to methodological quality. BMJ 2000;
320(7240):1007-1008.
PMID: 10753165
Sheiner LB, Rubin DB. Intention-to-treat analysis and the
goals of clinical trials. Clin Pharmacol Ther 1995; 57(1):6-15.
PMID: 7828382
Sheiner LB. Is intent-to-treat analysis always (ever)
enough? Br J Clin Pharmacol 2002; 54(2):203-211.
PMID: 12207643
Stern JM, Simes RJ. Publication bias: evidence of delayed
publication in a cohort study of clinical research projects. BMJ 1997;
315(7109):640-645.
PMID: 9310565
Tierney JF, Stewart LA. Investigating patient exclusion
bias in meta-analysis. Int J Epidemiol 2005; 34(1):79-87.
PMID: 15561753
Tramer MR, Reynolds DJ, Moore RA, Mcquay HJ. Impact of
covert duplicate publication on meta-analysis: a case study. BMJ 1997;
315(7109):635-640.
PMID: 9310564
Page last edited: 23 March 2010
